From a bestselling debut album to a life-threatening health scare, we're looking at the life of the legendary R&B singer Al B ...

Trump is reportedly considering a pardon for Diddy ahead of his sentencing, sparking controversy and political debate online.

Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by ...

Blue whales have gone silent. Why that has scientists worried about Earth’s biggest animals ... and the ocean ...

Piers Morgan is weighing in on the cancellation of “The Late Show With Stephen Colbert.” On Sunday morning, the TV ...

From innovation in manufacturing to more-flexible regulation and better communication with payers, much needs to happen to ...

Arike Ogunbowale isn’t just lighting up scoreboards, she’s shaping what star power looks like in Dallas. Her deal with the ...

For more than 30 years, scientists have studied how the myogenic determination gene number 1 (MYOD) protein binds DNA to modify the gene expression of muscle stem cells. MYOD is a transcription factor ...

Fortifying their bullpen for the stretch run, the New York Yankees acquired All-Star relievers David Bednar and Camilo Doval in separate deals as they made a flurry of moves Thursday just ahead of ...

The short-term loss of rookie quarterback Will Howard might complicate things. The former Ohio State star is dealing with a ...

A court verdict against Tesla last week, stemming from a fatal 2019 crash of an Autopilot-equipped Model S, could hurt its ...

Ultragenyx's UX111 gene therapy faces FDA delay due to facility issues; analysts adjust price targets amid uncertain resubmission timeline.